St. Louis, MO, and Moorestown, NJ, (June 7, 2018) – Tabula Rasa HealthCare (NASDAQ:TRHC), today announced Dorothy Ginsberg, RN, a senior PACE consultant, and Mandy Hurley, a marketing and enrollment consultant, have joined the company’s St. Louis-based consulting division, Capstone Performance Systems. Capstone provides Medicare risk adjustment and health plan management services to Programs of All-Inclusive Care for the Elderly (PACE) and similar value-based healthcare organizations.
PACE is a federal program, with 240 centers in 31 states serving a growing number of eligible Medicare and Medicaid participants. According to the National PACE Association, PACE technical assistance centers offer guidance to prospective PACE Providers, including PACE program operations, marketing and financing expertise. Pre-PACE Providers benefit from working with consultants who have in-depth experience in the development and implementation of PACE with the goal of building successful programs.
“We are pleased to welcome Dorothy and Mandy to the Capstone Team,” says Richard Schamp, MD, CEO of Capstone. “Their expertise in the PACE exploration and start-up phases, as well as in ongoing operations, will allow Capstone to broaden its offerings to PACE organizations in all phases of development and operations. Coupled with our recent addition of health plan management services, their joining our company means we can now offer a comprehensive menu of services for PACE organizations.”
Before joining Capstone, both Ginsberg and Hurley were with Altitude Edge Consultants, a national PACE consulting firm. Prior to that, Ginsberg served as the State of New Jersey’s PACE administrator where she led the development and implementation of PACE in the state and provided technical assistance to new programs. In her new role with Capstone, she will work with pre-operational clients through the program development process and the initial year of operation. Hurley will provide guidance with marketing and enrollment processes to both pre-operational and operating PACE programs. She previously led marketing initiatives for a North Carolina PACE program.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.